Skip to main content

Table 3 Multivariable analysis for patients after LRRT

From: Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy

Characteristic

Hazard ratio

95%CI

P value

No. of metastatic organs

 1

Reference

  

 > 1

2.177

1.445–3.281

< 0.001

No. of metastatic lesions

 ≤ 5

Reference

  

 > 5

2.772

1.860–4.132

< 0.001

EBV-DNA (Copies/ml)

 ≤ 25,000

Reference

  

 > 25,000

1.355

0.956–1.355

0.035

LRRT technique

 2DCRT

Reference

  

 IMRT

0.935

0.667–1.312

0.699